Washington, DC 20006-5349
HELPLINE
Today, the Meso Foundation wrote a letter to the acting administrator of the EPA urging the agency to account for legacy asbestos when evaluating asbestos risk and the magnitude of the asbestos problem. This letter came as a response to the EPA’s decision to exclude legacy uses of asbestos in its problem formulation. This issue is separate from the recently publicized ‘significant new use rule.’ You can read more here.
EPA_Legacy_Comment_MesoFoundation
Julie White, RN, OCN is an experienced oncology nurse with 18 years in the field. She holds a Bachelor of Science in Nursing and is
Peritoneal mesothelioma can be treated surgically (i.e. HIPEC) and/or systemically (chemotherapy or immunotherapy). This session features two medical oncologists and three peritoneal mesothelioma surgeons as
Genetic mutations coupled with environmental factors can lead to the development of cancer, including mesothelioma. Some of those mutations have prognostic implications, while others may
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
